Your browser doesn't support javascript.
loading
Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials.
Tam, C S; Kapoor, P; Castillo, J J; Buske, C; Ansell, S M; Branagan, A R; Kimby, E; Li, Y; Palomba, M L; Qiu, L; Shadman, M; Abeykoon, J P; Sarosiek, S; Vos, Jmi; Yi, S; Stephens, D; Roos-Weil, D; Roccaro, A M; Morel, P; Munshi, N C; Anderson, K C; San-Miguel, J; Garcia-Sanz, R; Dimopoulos, M A; Treon, S P; Kersten, M J.
Afiliación
  • Tam CS; Alfred Health, Monash University, Melbourne, Victoria, Australia. Electronic address: constantine.tam@alfred.org.au.
  • Kapoor P; Mayo Clinic, Rochester, MN.
  • Castillo JJ; Harvard Medical School, Dana Farber Cancer Institute, Boston. MA.
  • Buske C; Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.
  • Ansell SM; Mayo Clinic, Rochester, MN.
  • Branagan AR; Massachusetts General Hospital, Boston, MA.
  • Kimby E; Karolinska Institut, Stockholm, Sweden.
  • Li Y; Baylor College of Medicine, Houston, TX.
  • Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Qiu L; National National Clinical Medical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Shadman M; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA.
  • Abeykoon JP; Mayo Clinic, Rochester, MN.
  • Sarosiek S; Harvard Medical School, Dana Farber Cancer Institute, Boston. MA.
  • Vos J; Department of Hematology, Cancer Center Amsterdam/LYMMCARE, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Yi S; National National Clinical Medical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin 301600, China.
  • Stephens D; University of Utah Huntsman Cancer Institute, Salt Lake City, UT.
  • Roos-Weil D; Sorbonne University, Hematology Unit, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
  • Roccaro AM; ASST Spedali Civili, Brescia, Italy.
  • Morel P; Hematologie Clinique et Therapie Cellulaire, University Hospital Amiens Picardie, University of Picardie Jules Verne, France.
  • Munshi NC; Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.
  • Anderson KC; Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.
  • San-Miguel J; Clinica Universidad de Navarra, CCUN, CIMA, IDISNA, CIBERONC, Navarra, Spain.
  • Garcia-Sanz R; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.
  • Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Treon SP; Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.
  • Kersten MJ; Tianjin Institutes of Health Science, Tianjin 301600, China.
Semin Hematol ; 60(2): 118-124, 2023 03.
Article en En | MEDLINE | ID: mdl-37099031
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Macroglobulinemia de Waldenström Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Semin Hematol Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Macroglobulinemia de Waldenström Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Semin Hematol Año: 2023 Tipo del documento: Article